Protecting effects of 4-octyl itaconate on neonatal hypoxic-ischemic encephalopathy via Nrf2 pathway in astrocytes

Table 1 Primers used in this study

Primer	Forward sequence (5’-3’)	Reverse sequence (5’-3’)
IL-1β	CGTCTCCCAGAGCCAATCC	CACCAGGCTGACTTTGAGTGAGT
IL-6	ATCCAGTTGCCTTCTTGGGACTGA	TAAGCCTCCGACTTGTGAAGTGGT
C3	TTCCTTCACTATGGGACCAGC	TCCTTACTGGCTGGAATCTTGA
Ctla2a	GGTGAGAGCAGAGAAAAGCA	CTGTGTCTTTCTTCATTCAGATTGT
Ifi211	AGCTGATTCTGGATTGGGCA	TCACACACTTTCTGCGTGCT
Nfe2l2	ACTACAGTCCCAGCAGAGTGAT	TCACACACTTTCTGCGTGCT
Atf3	TACCGTCAACAACAGACCCC	CCAGTTTCTCTGACTCTTTCTGC
HO-1	CCGCTACCTGGGTGACCTCTC	CCTCTGACGAAGTGACGCCATC
β-actin	TAAAGACCTCTATGCCAACACAGT	CACGATGGAGGGGCCGGACTCATC

IL interleukin, C3 complement component 3, Ctla2a cytotoxic T lymphocyte-associated protein 2 alpha, Ifi211 interferon activated gene 211, Nfe2l2 nuclear factor, erythroid derived 2, like 2, Atf3 activating transcription factor 3, HO-1 heme oxygenase 1

ISSN: 1742-2094